Gilead Oncology Sales Take Off As Veklury’s Come Down To Earth
Q2 Saw Cancer Drug Sales Up 71%
As expected, the COVID-19 drug’s sales fell significantly, though it remains in frequent use among hospitalized patients. Meanwhile, oncology drug sales broke the half billion-dollar mark.
